Department of Anesthesiology and Intensive Care, University Hospital Münster
Münster, D-48149, Germany
NCT Number: NCT00662922
Hypoglycemia occurs frequently during intensive blood glucose control in critically ill patients. The incidence of hypoglycaemia is associated with impaired outcome. However, it is hitherto unknown if hypoglycaemia itself predisposes patients to neurological impairment, e.g. cognitive dysfunction, or if it is the underlying medical condition that makes the patient prone to a high risk of hypoglycaemia and, concomitantly, neurocognitive impairment. Therefore we investigate neurocognitive function in patients who had hypoglycemias during their intensive care stay and compare the results to patients without hypoglycaemia whose medical conditions are matched to the hypoglycaemia patients.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Münster, D-48149, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year after ICU discharge
Time frame: 2,3, and 4 years after ICU discharge
University Hospital Muenster
Other
Does Hypoglycemia Under Intensive Insulin Therapy During Critical Illness Lead to Neurocognitive Dysfunction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03890432
Critical Illness, Deficiency Diseases
Geneva, Canton of Geneva, Switzerland
View Trial DetailsNCT05442853
Critical Illness, Diabetes Mellitus
Gainesville, Florida, United States
View Trial DetailsNCT00694473
Critical Illness, Disease Attributes
Boston, Massachusetts, United States
View Trial DetailsNCT02056353
Critical Illness, Disease Attributes
Hasselt, Belgium
View Trial Details